Clinical Trials on Severe Acute Respiratory Syndrome

Total 11171 results

Assistance Publique - Hôpitaux de Paris

Completed

Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS (STROMA-CoV2)

Severe Acute Respiratory Syndrome Coronavirus 2 | Severe Acute Respiratory Distress Syndrome

France
NeuroActiva, Inc.

Unknown

Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831 (NEUROSIVIR)

Severe Acute Respiratory Syndrome | Covid19 | Corona Virus Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia | Neurodegeneration | Neuroinflammatory Response | Severe Acute Respiratory Infection | Severe Acute Respiratory Syndrome of Upper Respiratory Tract

United States
Oneness Biotech Co., Ltd.

Completed

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)

United States
Hôpital Universitaire Sahloul

Completed

Quercetin In The Treatment Of SARS-COV 2 (QUERCOV)

SARS (Severe Acute Respiratory Syndrome)

Tunisia
Wits Health Consortium (Pty) Ltd
Fred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; National Institute... and other collaborators

Completed

Sisonke (Together): OPEN LABEL TRIAL COVID-19 (Sisonke)

SARS (Severe Acute Respiratory Syndrome)

South Africa
Takeda

Completed

A Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

Japan
Laboratorios Silanes S.A. de C.V.

Completed

Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. (DMMETCOV19-2)

Severe Acute Respiratory Syndrome Coronavirus 2

Mexico
Throne Biotechnologies Inc.

Not yet recruiting

Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19

Severe Acute Respiratory Syndrome (SARS) Pneumonia
Massachusetts General Hospital
Xijing Hospital; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Niguarda...

Completed

Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 (NOSARSCOVID)

Coronavirus | SARS (Severe Acute Respiratory Syndrome)

United States, Sweden
University of Saskatchewan
Government of Canada; Vaccine Formulation Institute (VFI); Government of Saskatchewan and other collaborators

Completed

A Clinical Trial of COVAC-2 in Healthy Adults

Severe Acute Respiratory Syndrome Coronavirus 2

Canada
Pulmoquine Therapeutics, Inc
Rockefeller University

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers

Severe Acute Respiratory Syndrome Coronavirus 2

United States
University of Cape Town
University of KwaZulu

Unknown

African Covid-19 Critical Care Outcomes Study

Severe Acute Respiratory Syndrome Coronavirus 2

South Africa
University of Saskatchewan
Government of Canada; Vaccine Formulation Institute (VFI); Government of Saskatchewan and other collaborators

Completed

A Clinical Trial of COVAC-2 in Adults

Severe Acute Respiratory Syndrome Coronavirus 2

Uganda
University of Saskatchewan
Government of Canada; Government of Saskatchewan

Withdrawn

A Clinical Trial of COVAC-1, a COVID-19 Vaccine, in Generally Healthy Adults

Severe Acute Respiratory Syndrome Coronavirus 2
University Hospital, Strasbourg, France

Completed

Quantification of Radiological Pulmonary Involvement in Acute Respiratory Failure

SARS (Severe Acute Respiratory Syndrome)

France
ANRS, Emerging Infectious Diseases

Recruiting

Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection (SEVASAR)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

France, Martinique
University of Pecs
Hungarian Ministry of Innovation and Technology

Terminated

Study to Assess the Efficacy and Safety of Favipiravir-HU

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Hungary
Central Hospital, Nancy, France

Completed

PEEP Setting in COVID19-related ARDS

ARDS Due to Severe Acute Respiratory Syndrome Coronavirus 2

France
Cogna Technology Solutions LLC
Novavax

Completed

Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

United Arab Emirates
NeuroActiva, Inc.
Biomed Industries, Inc.

Recruiting

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection (NATADEX)

Coronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Severe Acute Respiratory Infection

United States
University Hospital, Basel, Switzerland

Completed

Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19 (COVID-RT-01)

Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)

Switzerland
Pomeranian Medical University Szczecin

Not yet recruiting

Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia.

Oxygen Deficiency | Corona Virus Infection | ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2

Poland
Vanderson Geraldo Rocha

Terminated

Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 (RUXO-COVID)

SARS-CoV2 | Severe Acute Respiratory Syndrome Coronavirus 2

Brazil
Saint Francis Care

Completed

Convalescent Plasma in the Treatment of COVID 19

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | COVID | Coronavirus

United States
Fundação de Medicina Tropical Dr. Heitor Vieira...

Completed

Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 (MetCOVID)

SARS-CoV Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia

Brazil
Grupo Cooperativo de Hemopatías Malignas

Completed

Treatment of SARS Caused by COVID-19 With Ruxolitinib

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2

Mexico
NMC Specialty Hospital

Completed

Communication in ICU During COVID-19

Severe Acute Respiratory Syndrome | COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2

United Arab Emirates
Fundação de Medicina Tropical Dr. Heitor Vieira...
Marcus Vinícius Guimarães de Lacerda; Mayla Gabriela Silva Borba; Wuelton Marcelo... and other collaborators

Completed

Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 (CloroCOVID19)

SARS-CoV Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia

Brazil
D'Or Institute for Research and Education
Oswaldo Cruz Foundation; Rio de Janeiro State Research Supporting Foundation... and other collaborators

Not yet recruiting

Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure

Pneumonia | Acute Respiratory Distress Syndrome (ARDS) | Severe Acute Respiratory Syndrome (SARS)

Brazil
Institut Pasteur

Completed

Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19] (COVID-OISE)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

France
Pine Trees, Inc.
Piedmont Healthcare; ICON plc; MRI Global; ASCLEPES Research Center; Eastside Research... and other collaborators

Completed

A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care

Covid19 | SARS (Severe Acute Respiratory Syndrome)

United States
Applied Biology, Inc.

Completed

Proxalutamide Treatment for Hospitalized COVID-19 Patients

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Brazil
Ministry of Public Health, Argentina

Completed

Ivermectin Reproposing for Mild Stage COVID-19 Outpatients (IVER-Leve)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Argentina
Hôpital Universitaire Sahloul

Recruiting

Colloidal Silver, Treatment of COVID-19

SARS (Severe Acute Respiratory Syndrome)

Tunisia
Institut Pasteur

Completed

Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France (CORSER)

COVID-19 | SARS (Severe Acute Respiratory Syndrome)

France
Apsen Farmaceutica S.A.
Federal University of São Paulo

Withdrawn

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Infections | SARS-CoV 2 | Pulmonary Disease | SARS (Severe Acute Respiratory Syndrome)

Brazil
Shahid Beheshti University of Medical Sciences

Unknown

Low Dose Radiotherapy in COVID-19 Pneumonia

COVID | SARS (Severe Acute Respiratory Syndrome)

Iran, Islamic Republic of
Applied Biology, Inc.

Withdrawn

Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Brazil
B. Braun Melsungen AG
CeGaT GmbH

Completed

Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Germany
Maria de los Angeles Peral de Bruno

Completed

Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan (Ivercar-Tuc)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Argentina
Elizabeth Glaser Pediatric AIDS Foundation
Find; Kiambu County

Completed

Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2

Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Kenya
AbbVie

Completed

A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois (CONTACT)

Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)

United States
International Brain Research Foundation

Withdrawn

Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Covid19 | SARS (Severe Acute Respiratory Syndrome)
Goethe University
Nationwide Network of University Medicine (NUM) on Covid-19

Recruiting

Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON) (SUEP-NAPKON)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Germany
University of Saskatchewan
Government of Canada; Government of Saskatchewan

Active, not recruiting

A Clinical Trial to Study the COVAC-1 Booster Dose in Generally Healthy Adults

Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Canada
Synairgen Research Ltd.

Completed

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 (SPRINTER)

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2

United Kingdom, Italy, United States, Portugal, Israel, Germany, Belgium, India, Spain, Netherlands, Argentina, Brazil, Colombia, France, Mexico, Romania, Serbia
Lahore General Hospital

Unknown

Methylprednisolone in COVID-19 Patients (Methyl19LGH) (Methyl19LGH)

SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

Pakistan
Pontificia Universidad Catolica de Chile
Fundacion Arturo Lopez Perez

Completed

Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection

Severe Acute Respiratory Syndrome Coronavirus 2

Chile
University of Cagliari

Completed

Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery

Covid19 | Surgery | SARS (Severe Acute Respiratory Syndrome)

Italy
Hôpital Universitaire Sahloul

Completed

The Effectiveness of Phytotherapy in SARS-COV2(COVID-19) (Quercetix)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | a Randomized Double-blind Study | PHYTOTHERAPIE

Tunisia

Clinical Trials on Severe Acute Respiratory Syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations